Stratification of patients with severe asthma

被引：8

作者：

Bousquet, Jean ^{[1
,2
,3
]}

机构：

[1] CHU Montpellier, Montpellier, France

[2] INSERM, U1168, Paris, France

[3] Univ Versailles, UMR S 1168, St Quentin En Yvelines, France

来源：

LANCET RESPIRATORY MEDICINE | 2015年 / 3卷 / 05期

关键词：

EOSINOPHILIC ASTHMA; PERSISTENT ASTHMA; ALLERGIC-ASTHMA; MEPOLIZUMAB; OMALIZUMAB; ANTIBODY;

D O I：

10.1016/S2213-2600(15)00057-0

中图分类号：

R4 [临床医学];

学科分类号：

100218 [急诊医学];

摘要：

引用

收藏

页码：330 / 331

页数：2

相关论文

共 9 条

[1]

Predicting and evaluating response to omalizumab in patients with severe allergic asthma [J].

Bousquet, J. ;

Rabe, K. ;

Humbert, M. ;

Chung, K. F. ;

Berger, W. ;

Fox, H. ;

Ayre, G. ;

Chen, H. ;

Thomas, K. ;

Blogg, M. ;

Holgate, S. .

RESPIRATORY MEDICINE, 2007, 101 (07) :1483-1492

[2]

Castro M, 2015, LANCET RESP MED

[3]

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study [J].

Castro, Mario ;

Wenzel, Sally E. ;

Bleecker, Eugene R. ;

Pizzichini, Emilio ;

Kuna, Piotr ;

Busse, William W. ;

Gossage, David L. ;

Ward, Christine K. ;

Wu, Yanping ;

Wang, Bing ;

Khatry, Deepak B. ;

van der Merwe, Rene ;

Kolbeck, Roland ;

Molfino, Nestor A. ;

Raible, Donald G. .

LANCET RESPIRATORY MEDICINE, 2014, 2 (11) :879-890

[4]

A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma [J].

Flood-Page, Patrick ;

Swenson, Cheri ;

Faiferman, Isidore ;

Matthews, John ;

Williams, Michael ;

Brannick, Lesley ;

Robinson, Douglas ;

Wenzel, Sally ;

Busse, William ;

Hansel, Trevor T. ;

Barnes, Neil C. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (11) :1062-1071

[5]

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma [J].

Haldar, Pranabashis ;

Brightling, Christopher E. ;

Hargadon, Beverley ;

Gupta, Sumit ;

Monteiro, William ;

Sousa, Ana ;

Marshall, Richard P. ;

Bradding, Peter ;

Green, Ruth H. ;

Wardlaw, Andrew J. ;

Pavord, Ian D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) :973-984

[6]

Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study [J].

Hanania, Nicola A. ;

Wenzel, Sally ;

Rosen, Karin ;

Hsieh, Hsin-Ju ;

Mosesova, Sofia ;

Choy, David F. ;

Lal, Preeti ;

Arron, Joseph R. ;

Harris, Jeffrey M. ;

Busse, William .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (08) :804-811

[7]

Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma - A pilot study 164/rccm.200206-5250C [J].

Kips, JC ;

O'Connor, BJ ;

Langley, SJ ;

Woodcock, A ;

Kerstjens, HAM ;

Postma, DS ;

Danzig, M ;

Cuss, F ;

Pauwels, RA .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (12) :1655-1659

[8]

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia [J].

Nair, Parameswaran ;

Pizzichini, Marcia M. M. ;

Kjarsgaard, Melanie ;

Inman, Mark D. ;

Efthimiadis, Ann ;

Pizzichini, Emilio ;

Hargreave, Frederick E. ;

O'Byrne, Paul M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) :985-993

[9]

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma [J].

Ortega, Hector G. ;

Liu, Mark C. ;

Pavord, Ian D. ;

Brusselle, Guy G. ;

FitzGerald, J. Mark ;

Chetta, Alfredo ;

Humbert, Marc ;

Katz, Lynn E. ;

Keene, Oliver N. ;

Yancey, Steven W. ;

Chanez, Pascal .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13) :1198-1207